Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
actgnetwork.orgTotal trials
70
Active
6
Phase 3
8
Total enrollment
45,242
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Transdermal estradiol gel | — | — | — | — | — | 1 | |
| Micronized Progesterone | — | — | — | — | — | 1 | |
| 3BNC117-LS | — | — | — | — | — | 1 | |
| 10-1074-LS | — | — | — | — | — | 1 | |
| ID93 + GLA-SE vaccine | — | — | — | — | — | 1 | |
| 3BNC117-LS-J | — | — | — | — | — | 1 | |
| 10-1074-LS-J | — | — | — | — | — | 1 |
Next readouts
- 2025-10-14
- 2027-09-20
- 2028-10-31
- 2029-02-16
Top conditions
- HIV-1 Infection30
- HIV Infections22
- HIV Infection7
- Tuberculosis7
- HIV-1-infection6
- Hepatitis C2
- Tuberculosis, Pulmonary1
- Hepatitis1
Frequently asked questions about Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- How many clinical trials does Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections have on ClinicalTrials.gov?
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections is listed as the lead sponsor on 70 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections's trials are in Phase 3?
- 8 of Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections focus on?
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections's most-studied conditions on ClinicalTrials.gov are HIV-1 Infection, HIV Infections, HIV Infection, Tuberculosis, HIV-1-infection.
- When are Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections's next clinical trial readouts?
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections has 4 upcoming primary-completion readouts tracked here; the soonest is “Pausing Antiretroviral Treatment Under Structured Evaluation”, expected around 2025-10-14.